Evidence map›Paper›PMID 40303573›Full record

ArticleInternational journal of nanomedicine2025

Combined Mulberry Leaf Polysaccharide-Caged Liposomes for Effective Oral Drug Delivery in Rat Model.

Xiaolan Chen, Han Zhou, Asly Chua An Wen, Shengyi Wang, Lei Zhang, Haifeng Yang, Yujuan Mao, Jiping Jia, Dada Wang, Jing Wang and 6 more

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Xiaolan Chen *Jiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Han Zhou *Department of Pharmaceutics, China Pharmaceutical University, Jiangsu, 210009, People's Republic of China.ORCID 0009-0006-8320-3613
Asly Chua An WenDepartment of Pharmaceutics, China Pharmaceutical University, Jiangsu, 210009, People's Republic of China.
Shengyi WangDepartment of Pharmaceutics, China Pharmaceutical University, Jiangsu, 210009, People's Republic of China.
Lei ZhangDepartment of Pharmaceutics, China Pharmaceutical University, Jiangsu, 210009, People's Republic of China.
Haifeng YangJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Yujuan MaoJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Jiping JiaJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Dada WangJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Jing WangJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Zhaoli CaoJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.
Bohui XuSchool of Pharmacy, Nantong University, Jiangsu, Nantong, People's Republic of China.ORCID 0000-0002-2551-6420
Ying XuCollege of Pharmacy, Jiangsu University, Zhenjiang, 212013, People's Republic of China.
Yan ShenDepartment of Pharmaceutics, China Pharmaceutical University, Jiangsu, 210009, People's Republic of China.
Wenli ZhangDepartment of Pharmaceutics, China Pharmaceutical University, Jiangsu, 210009, People's Republic of China.
Yi ZhengJiangsu Agri-Animal Husbandry Vocational College, Taizhou, Jiangsu, People's Republic of China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Mulberry leaf polysaccharide (MLP) has gained attention as a potential anti-diabetic agent for lowering blood glucose and improving insulin sensitivity. However, the low gastrointestinal stability and oral bioavailability limit its clinical application. To address this issue, a novel drug-caged liposomes (MLP-CL) was developed to enhance oral delivery efficiency of MLP compared to conventional drug-encapsulated liposomes (MLP-L). Methods: MLP-L and MLP-CL were prepared by the thin-film hydration method. Subsequently, the structural integrity of these liposomes was assessed via in vitro release test and confocal laser microscopy (CLSM) analysis. Madin-Darby canine kidney (MDCK) cells were employed to investigate the cellular uptake mechanisms and transcellular transport efficiency. Finally, the biodistribution profiles and transport mechanisms of liposomes were evaluated through in vivo fluorescence imaging and pharmacokinetic studies in Sprague Dawley rats. Results: Compared to MLP-L, which released 80% of MLP within 4 hours, MLP-CL showed sustained release with only 40% released in the same period. MLP-CL also enabled more effective co-delivery of MLP and liposomes to MDCK cells, indicating improved structural integrity and cellular uptake. Transcellular transport assay confirmed that MLP-CL was transported across cells more efficiently. In vivo, MLP-CL increased intestinal accumulation and raised plasma MLP concentration by 50%. Additionally, by comparing the discrepancy between the lymphatic-suppression model and the normal model, it was found that 63.56% of MLP-CL was absorbed through the lymphatic pathway compared to 18.05% for MLP-L. Conclusion: Compared to conventional MLP-L, conjugation of polysaccharide improves the structural integrity of MLP-CL in the gastrointestinal tract, which in turn improves lymphatic uptake and bioavailability. This provides an effective strategy for the design of polysaccharide delivery systems.

Indexed as

Drug Delivery SystemsLiposomesMorusPlant LeavesPolysaccharidesAdministration, OralAnimalsBiological AvailabilityDogsDrug LiberationMadin Darby Canine Kidney CellsMaleRatsRats, Sprague-DawleyTissue DistributionLiposomesPolysaccharidesbioavailabilitydiabetes managementliposomemulberry leaf polysaccharidesoral drug delivery

Identifiers

PMID40303573
PMCPMC12039930

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.